1

BIO issues glowing report on US Bioscience Industry

I’ll be posting more soon about the 2018 Biotechnology Innovation Organization’s  International Convention, where I spent the day on Monday, but thought the following press release might be of interest.  Despite the glowing industry review,  many sessions dealt with difficulties the industry is facing. The release follows.

–Anita M. Harris

A study released on June 5  at the BIO International Convention in Boston shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry has held a leading position as an economic driver and job generator.

The report, Investment, Innovation and Job Creation in a Growing U.S. Bioscience Industry 2018, finds U.S. bioscience firms directly employ 1.74 million people, a figure that includes more than 273,000 high-paying jobs created since 2001. The average annual wage for a U.S. bioscience worker reached $98,961 in 2016. These earnings are more than $45,000 greater, on average, than the overall U.S. private sector wage. The report further shows that since 2014, the bioscience industry has grown by 4.4 percent with four of its five major subsectors contributing to this overall job gain.

For the first time, the biennial report includes a full assessment of the economic impact of the bioscience industry and finds its total economic impact on the U.S. economy, as measured by overall output, totaled $2 trillion in 2016. This impact is generated by the direct output of the bioscience industry combined with the indirect (supply chain) and induced (employee spending) impacts. The industry and its associated economic output support 8 million jobs throughout the entire U.S. economy through both indirect and induced effects.

“This report highlights the enormous economic impact delivered by our industry. This strong performance is due to the vital and wide-ranging collaborations between industry partners, universities, and policymakers that provides a business climate that supports the development of innovative bioscience products and high paying jobs,” said Jim Greenwood, President and CEO of the Biotechnology Innovation Organization.”

The report also takes the pulse of the broader U.S. innovation ecosystem for bioscience companies and finds it advancing with positive results. The U.S. is experiencing strong gains in bioscience venture capital funding, growth in patents, a recent ramp-up in bioscience-related university R&D expenditures and increasing research funding from the National Institutes of Health (NIH).

“The bioscience industry is vital to the U.S. not only as an innovation engine that is improving lives, but also as a major economic driver that is consistently generating high-quality jobs and significant economic output across the nation,” said Ryan Helwig, Principal and Project Director with TEConomy Partners.

The state-by-state industry assessment is the eighth in a biennial series, developed in partnership by TEConomy and BIO, presenting data on national, state, and metropolitan area bioscience industry employment and recent trends.

Additional highlights from the industry economic analysis include:

  • The industry is a major economic driver and is well distributed across U.S. states and cities:
    • 41 states experienced net job growth in the biosciences between 2014-2016
    • 38 states and Puerto Rico have an employment specialization in at least one bioscience subsector
    • 213 of 383 U.S. metropolitan areas have at least one bioscience specialization

Highlights from the analysis of the innovation ecosystem for the bioscience industry include:

  • Strength in recent venture capital and patenting trends:
    • Venture capital investments have reached new highs. More than $66 billion in venture capital was invested in bioscience companies during the 2014 through 2017 period, including a new annual high in 2017 at $20 billion invested.
    • Innovation continues to drive the biosciences, since 2014 the U.S. has increased patent totals in bioscience-related technology classes by nearly 5 percent, or 1.6 percent per year, on average. 2017 had a total of nearly 27,000 patents awarded to U.S. inventors, another new high.
  • Growth for academic biosciences R&D in 2016
    • After several years of concerns raised about the declining and/or flat NIH research budgets and the subsequent effects on academic and other research, NIH funding is back on the rise. There have been budget increases sustained each of the last three years.
    • Across America’s colleges and universities, the pace of R&D spending in bioscience-related research areas has increased. Following a 1.5 percent decline in 2015, academic R&D expenditures in the biosciences increased 5.5 percent to $42 billion in 2016.

The TEConomy/BIO report includes individual profiles for all 50 states, the District of Columbia and Puerto Rico, and can be found on the BIO website at bio.org/jobs2018.

About BIO
BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO’s blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

About TEConomy
TEConomy Partners, LLC is a global leader in research, analysis, and strategy for innovation-based economic development. Today we’re helping nations, states, regions, universities, and industries blueprint their future and translate knowledge into prosperity. The Principals of TEConomy Partners include the authors of the prior Battelle/BIO State Bioscience Development reports, published since 2004. For more information, please visit http://www.teconomypartners.com.




BIO-IT World 2018 awards top innovators at Boston Conference-Expo

Spent an interesting Wednesday afternoon, last week,  visiting exhibitors at the Bio-IT World Conference & Expo –several of whom won “Best of Show” Awards later that day.

The judges, listed below,  named winners in six categories: Data Integration & Management; Analysis & Data Computing; Genomic Data Services; Data Visualization & Exploration; Storage Infrastructure & Hardware; and the Judges’ Prize.  Attendees also voted on the People’s Choice Award, selecting products that they believed measurably improve workflow or capacity, enabling better research.

One of my favorites was Nanome, which won best in show for Data Visualization and Exploration.
Nanome uses virtual reality to improve the drug discovery process, according to its award application. The company offers applications for experimentation, collaborattion, and learning at the nano-scale– leveraging  VR hardware such as the Oculus Rift and HTC Vive to create immersive virtual workspaces allowing users to visualize, design, and simulate molecules, proteins, and more.

At  Nanom’se i BIO–IT World booth, Marketing Director Jarrell James handed me a pair of VR goggles and two joysticks (?) with which  I could explore within a molecule–by seeming to make components larger, smaller or revolve.

A more sophisticated user might be able to:

  • -Import molecular structures from a local machine or an online database such as RCSB or DrugBank.
  • – Manipulate molecular structures by literally grabbing, rotating, or enlarging the area of interest with their hands.
  • – Apply different representations to their selection of Atoms, Residues, Chains, or Proteins such as Stick, Wire, Ball & Stick, or Van der Waals.
  • – Measure distances and angles between atoms.
  • – Mutate amino acids and cycle through rotamer libraries.
  • – Design small molecules by building with any element from the periodic table.
  • – Minimize manipulated molecules to prevent clashes and provide a local energy minimum conformation.
  • – Duplicate or Split any selected area of your structure to modify or export independently.
  • – Export your molecular structures to PDB.
  • – Join a virtual reality session as a guest with or without virtual reality hardware.
  • – Present and collaborate in the same virtual environment with colleagues to demonstrate proposals or compare before and after results.

Nanome plans next to enter the education space. The company’s VR technology wil help high school and college students , likely already proficient in gaming technology,  better understqand biologic processes, James said.

 

 

The Hyve 

I also spent some time with the folks at Hyve…whose fake robot ( that is, a “robot inhabited” by a human) did make me  curious about Hyve’s work.


RADAR-base
radar-cns.org

As described in the company’s award submission,  the company’s RADAR-base, developed in the framework of the IMI RADAR-CNS project, is an open source platform designed to securely collect, store and share readings from wearable devices and smartphone sensors to enable remote monitoring. The RADAR-base platform consists of three major categories of components:

 

  • Data ingestion: Recognizing and registering data-sources (including smartphones and wearable devices), collecting the data via a direct Bluetooth connection or through a 3rd party API and streaming in near real time to the server (green box in the figure). Using Apache Kafka, the collected data is streamed to dedicated topics in real-time where the data is optimally schematized using Apache Avro;
  • Data storage and management: Consists of two centralized storage systems behind an authorized security layer. A cold-storage based on HDFS that is scalable and fault-tolerant focusing on storing large volumes of high frequency raw-data, and a hot-storage based on MongoDB storing aggregated data to provide a near real-time overview of the raw-data. (blue box in the figure);
  • Data sharing: Visualizing aggregated data in a live dashboard and exporting raw data for further analyses in various formats including AVRO, JSON and CSV (yellow box in the figure).

The platform is highly secured by a centralized management system of users and their authorities, participants, allowed devices and their specifications. RADAR-Base platform is distributed as Docker containers with associated scripts and configuration files to enable easy installation.

 

 

 In addition, I  visited Sinequa, which took the prize in the Analysis & Data Computing category. 

 

 

 

 


Sinequa ES v10
sinequa.com

The Sinequa Cognitive Search and Analytics platform handles all structured and unstructured data sources and uses Natural Language Processing (NLP), statistical analysis and Machine Learning (ML) in order to create an enriched “Logical Data Warehouse” (LDW). This LDW is optimized for performance in delivering rapid responses to users’ information needs. Users can ask questions in their native language or ask that relevant information be “pushed” to them in a timely fashion when it emerges.

More than 180 connectors ready for use “out of the box” make the process of connecting multiple data sources fast and seamless. Company and industry-specific dictionaries and ontologies can be easily integrated, putting specific knowledge “under the hood” of the Sinequa platform, making it an intelligent partner for anyone in search of relevant subject information.

 

Other awards, as descrbed in company literature: :

Genomic Data Services

Diploid
Moon 1.0
diploid.com/moon

Moon is the first software to autonomously diagnose rare diseases from WES/WGS data. By applying AI to the domain of rare disease diagnostics, Moon brings speed and scalability to the genome interpretation process.

The software only requires the patient’s gender, age of onset and his/her symptoms – in addition to the genetic data. Moon then goes from whole genome variant data (VCF) to pinpointing the causal variant in less than 5 minutes.

The software highlights one or a few variants that could explain the patient’s phenotype. For every variant, Moon displays an extensive list of annotations that it mined from the literature, allowing geneticists to easily verify decisions from the AI algorithms. Moon’s speed does not only save a lot of time and money, it also saves lives: Moon has already proven its utility in the NICU at Rady Children’s Hospital (San Diego): https://goo.gl/7TDrQD.

Unfortunately, about 50% of rare disease patients remain undiagnosed, even after whole genome sequencing and expert interpretation. Most hospitals don’t have the resources to keep analyzing negative cases even though new correlations between genes and disorders are published every day. Moon changes all this: as the software autonomously mines the literature and analyses samples, it can reanalyze older, negative cases in the background. Only when new information that might lead to a diagnosis becomes available, the assigned geneticist is notified. That way, hospitals can frequently reanalyze thousands of cases with minimal labor, providing a perspective to undiagnosed patients.

 

Storage Infrastructure & Hardware

PetaGene
PetaSuite Cloud Edition – Version 1.2
petagene.com

Launching at Bio-IT World 2018, PetaSuite Cloud Edition (CE) combines two innovations: (i) the ability for a user’s software tools and pipelines to seamlessly integrate with a wide variety of cloud platforms without modification, and (ii) significantly improved, high-performance, scalable PetaSuite genomic compression technology. 

For example, users can now directly run, without modification, their custom BWA-mem, GATK, Python, Java, shell scripts, and other POSIX-based software/pipelines streaming directly to/from AWS, Google Cloud, Azure, and private cloud storage, as though they were local filestores. PetaSuite CE supports each platform’s object encryption during transfer and at rest. User applications can connect to multiple cloud platforms, buckets and regions as desired, transparently, and on demand, in user-mode, without needing to modify their pipelines, setup mounts, or have administrator privileges.

Whether running on bare-metal, in VMs, or within Docker containers, for public, private or hybrid cloud, PetaSuite CE enables organizations to unlock the power of distributed object storage seamlessly from their POSIX-compliant tools and pipelines.

PetaSuite CE is built from the ground-up for the extremely high performance streaming and random-access workloads demanded by genomics applications. The integrated, transparent PetaGene compression has been significantly improved to deliver even faster compression and greater reductions of up to 6x of both BAM and FASTQ.GZ files, enabling large costs savings in cloud storage and data transfer times. Moreover, PetaGene compression can also preserve the MD5 checksum of the original BAM or FASTQ.GZ file and not just the internal raw SAM/FASTQ data.

 

The Judges’ Prize went to 

 Linguamatics and its iScite 2.0 (iscite.com) provide a Software-as-a-Service search application that puts the power of text analytics directly into scientists’ hands, according to the company writeup.

Using Linguamatics’ Award-winning Natural Language Processing
Researchers can extract and analyze relevant data to rapidly answer business-critical questions. iScite utilizes Linguamatics’ award-winning Natural Language  L(NLP) based blend of analytical methods. By understanding the semantics and structure of text, iScite handles the variety of ways people express the same information, ensuring searches are comprehensive and accurate.

Easy to use on any device
iScite’s intuitive HTML interface includes a simple search box and auto-complete suggestions. The innovative answer-routing engine lets users answer simple or complex questions using puzzle-piece building blocks – simplifying access to powerful queries that extract concepts, relationships, numerical data such as drug dosages, mutations and more.

Get answers to questions, not just documents
Data sources include Linguamatics’ cloud-hosted content. MEDLINE, Clinical Trials.gov, FDA Drug Labels, PubMed Central, and Patent Abstracts are annotated with curated terminologies for diseases, drugs, genes and organizations. Scientists can answer questions such as:

  • What genes are involved in breast cancer?
  • What protocol designs have been used for immuno-oncology trials?
  • What are the adverse events for kinase inhibitors?

Actionable results
Results are presented in structured form, with bar chart facets for dynamic, visual results-filtering, a document viewer that highlights key terms and relationships, and relevant link-outs. Users can curate, save, and export their results.

iScite allows users across drug discovery and development to cut through the vast information landscape and discover the most valuable insights.

 

The People’s Choice award went to 

OnRamp BioInformatics, Inc. and itsROSALIND™ platform:  the first-ever genomics analysis platform specifically designed for life science researchers to  analyze and interpret datasets, while freeing up more time for bioinformaticians.

Named in honor of pioneering researcher Rosalind Franklin, who made a major contribution to the discovery of the double-helix structure of DNA with her famous photograph 51, OnRamp’s ROSALIND platform aims to simplify the practice of genomic data interpretation. According to the company’s writeup,  ROSALIND puts the researcher into the driver’s seat of data analysis and democratizes bioinformatics by broadly expanding access to genomic and proteomic technologies for cancer research, precision medicine and sustainable agriculture.

While many open-source tools remain the lifeline of genomic analysis, a simplified and innovative user experience for the biologist can empower them to run their own analyses, while utilizing these tools without the need for typing any command-line instructions.

ROSALIND is powered in partnership with Google Cloud and features scalable compute power and economical cloud-based storage. ROSALIND is a swarming docker-based genomic analysis solution incorporating the industry’s most trusted open-source tools and algorithms, with an angular front-end and secure RESTful API. ROSALIND is also deployable on-premise.

On Ramp technololgists believe that empowering biologists with “an intuitive and comprehensive platform” to explore their data and collaborate with colleagues and bioinformaticians, they  can help accelerate their industry and the widespread adoption of genomic technologies by dramatically lowering costs, reducing  complexity and, ultimately, focus more on what what to do with results, rather than on how to get to them.

 

In the words of Allison Profitt, BIO-IT World’s editor,” The awards program recognizes the best of the innovative product solutions for the life sciences industry on display at the conference,

“It’s always a treat to explore what’s new in our industry.

” The innovation on display by Bio-IT World exhibitors never disappoints, and we are excited to shine a spotlight on the best life sciences has to offer.”

Judges
“The Best of Show program relies on a panel of expert judges from academia and industry who screen eligible new products and hear presentations from a list of finalists on site. This year our judges considered 46 new products and viewed presentations on site from 18 finalists.”

The 2018 judging panel included Joe Cerro, BostonCIO; Chris Dwan, Bridgeplate; Richard Holland, New Forest Ventures; Eleanor Howe, Diamond Age Data Science; Phillips Kuhl, Cambridge Healthtech Institute; Steve Marshall, Marshall Data Solutions; Michael Miller, Genentech; Art Morales, Analgesic Solutions; Nanguneri Nirmala, Tufts University School of Medicine; Alexander Sherman, Massachusetts General Hospital; Subi Subramanian, Vertex Pharmaceuticals; Bill Van Etten, BioTeam; and Proffitt.

 

–Anita M. Harris
Anita Harris is a science writer based in Cambridge, MA. 
New Cambridge Observer is a publication of the Harris Commmunications Group, also in Cambridge, ma.  




Georgia O’Keeffe Inspirational at the Peabody Essex

Still thinking about the fabulous Georgia O’Keeffe show I saw last Sunday at the Peabody Essex Museum, in Salem, MA. “Georgia O’Keeffe: Art, Image, Style,”  is a retrospective going back to O’Keeffe’s high school years. It continues through her experiences in Chicago, Texas, New York City, Lake George, New Mexico and beyond her lifetime, to the present day.

 

 

The exhibit  features not only her art work through those years, but also year-book entries, photos of and by O’Keeffe, video of a conversation in which she says she was lucky that her work coincided with her time and was liked but that her paintings might have been better if she’d remained unknown.

Central to the show is the distinctive clothing she designed and wore–presented in relation to her paintings.

 

 

 

 

The show includes video from a 2018 fashion show in which models prance on a runway. wearing styles like those originated by OKeefe.(immediately below)

My friend E remarked on O’Keeffe as a feminist force. But while O’Keeffe was a ground breaker in the art world and is sometimes referred to as “the mother of abstract art,” a PEM commentary points out that she insisted throughout her career that she did not want to be considered a female artist…but simply an artist.

I did wonder what would have happened if famed New York City photographer Alfred Stieglitz, 30 years her senior, had not seen her work when she was a young artist and championed it–and her; if she had not moved to New York and married him; if he had not taken and shown photograph after photograph of her; if she had not had the safety and freedom afforded by Stieglitz and his family wealth in NY and Lake George. But an example of the early commercial artwork (left), on which she embarked to supplement her Texas teaching salary, makes me certain she would have become renowned on her own.

 

 

While I love most of O’Keeffe’s  paintings, I’m less enamoured of her fashion, which the show presents as an element of her artwork.  In my view, it seems to have become more traditionally masculine–with chunky-looking  black suits ordered from a men’s clothier in Hong Kong– as she moved on in life.(Or, as women’s societal roles changed?) 

 

 

 

 

 

 

 

 

 

 

 

I’ve  seen quite a few O’Keeffe shows over the years..several in New York, and one in Glens Falls, NY, near Lake George– but this is the first I’ve seen that incorporates and integrates so many aspects of her life.

I would have liked to have been told a bit more about O’Keeffe’s childhood and family and about her relationship with Stieglitz, but then, there’s Wikipedia for that. All in all, I found the exhibit of an artist who worked well into her 90s enriching and inspirational.

 

Should also mention the wonderful docent and ceramic artist/jewelry maker who told me that the unlabelled photos were taken by O’Keefe and encouraged me and other visitors to share our comments and photos on Instagram.  Also, btw, the PEM  cafeteria serves the richest, thickest hot chocolate I’ve ever tasted.

Georgia O’Keefe, Art, Image, Style will be at the Peabody Essex Museum, Salem, MA, Dec. 1-April 1, 2018. 

–Anita Harris
Anita M. Harris is a writer, photographer and communications consultant  basedin Cambridge, MA. She is the author of Ithaca Diaries, Coming of Age in the 1960s, and Broken Patterns: Professional Women and the Quest for a New Feminine Identity.

New Cambridge Observer is a publication of the Harris Communications Group, a PR and content marketing firm based in Kendall Square. :




Women’s March Photos, Cambridge 2018

Had a great time at this year’s women’s march…Much good cheer; great signage, and a wide range of participants. At about 2 pm, half-way through, a police officer told me that the crowd estimate was 4000…but he believed the number of participants was twice that, and I’d guess even a few more. (Given that there were only about 10 porta-potties, I’d also guess that was many more than the organizers expected). The sound system left something to be desired (from my perch on a monument, I could see the speaker but not hear an understandable word) but I much enjoyed the creativity of the signage and enthusiasm of the attendees.

–Anita Harris
Anita M. Harris is a writer and communications consultant based in Cambridge, MA. She is the author of Broken Patterns, Professional Women and the Quest for a New Feminine Identity  

and Ithaca Diaries, Coming of Age in the 1960s. 

New Cambridge Observer is a publication of the Harris Communications Group, a pr and content marketing firm  in Cambridge.

This slideshow requires JavaScript.




Free chocolate tasting Sat Jan 27: Harvard Square!

This just in From the Harvard Square Business Association…Yes, I stood in line last year and will likely do so again! 
–Anita Harris

The Legendary 10th Taste of Chocolate Festival in Harvard SquareFriday, January 26th – January 28th, 2018

January 17, 2018 (Cambridge, MA) The wait is over!  The Harvard Square Business Association is thrilled to announce the highly anticipated annual Taste of Chocolate Festival.  The highlight of this beloved weekend extravaganza is the free Chocolate Tasting Event on Saturday, January 27th from 1pm – 2pm.  Please join us on Brattle Plaza (in front of Brattle Square Florist at 31 Brattle Street) for heavenly chocolate treats from some of Harvard Square’s most loved restaurants!Come early!  This celebration of all things chocolate attracts hundreds of chocoholics!  Bring your dancing shoes (or boots!  It’s a great way to burn off those calories you will consume!) – once again, our friends Grooversity will warm the crowd with their infectious and heart stopping percussion combining traditional Brazilian grooves like Samba and Axe with Funk, Rock, Jazz and even Hip Hop.

 Special thanks to our sponsor, Getaround for supporting this event.
Salsa, Merengue and Reggaeton your way around Winter Carnival with some of Wellbridge Athletic Club’s finest Zumba instructors!  Join in the hottest fitness dance craze right here in Harvard Square – see what all the fun is about, and shake off those winter blues!  1:00pm – 1:30pm on Palmer Street, right by the chocolate!
In addition, chocolate promotions and sweet deals are on full display all weekend throughout the Square.  Businesses looking forward to welcoming you to the sweetest weekend of the year include:
For more information about this event and all events in Harvard Square, please visit harvardsquare.com.
Anita Harris is a writer, communications consultant and chocolate lover who lives and works in Cambridge.
New Cambridge Observer is a publication of the Harris Communications Group, an award-winning PR and content marketing firm based in Cambridge, MA.